DavisHMastTYoshieNZerlinS. The slow response of the human cortex to auditory stimuli: Recovery process. Electroencephalogr Clin Neurophysiol1966; 21: 105–113.
2.
PatrickGStraumanisJJStruveFAFitz-GeraldMJLeavittJMannoJE. Reduced P50 auditory gating response in psychiatrically normal chronic marihuana users: A pilot study. Biol Psychiat1999; 45: 1307–1312.
3.
AdlerLEGarhardtGAFranksR. Sensory physiology and catecholamines in schizophrenia and mania. Psychiat Res1990; 31: 297–309.
4.
AdlerLEPachtmanEFranksRDPecevichMWaldoMCFreedmanR. Neurophysiological evidence for a deficit in neuronal mechanisms involved in sensory gating in schizophrenia. Biol Psychiat1982; 27: 183–192.
5.
CullumCMHarrisJGWaldoMC. Neurophysiological and neuropsychological evidence for attentional dysfunction in schizophrenia. Schizophrenia Res1993; 10: 131–141.
6.
FreedmanRAdlerLEWaldoMCPachtmanEFranksRD. Neurophysiological evidence for a defect in inhibitory pathways in schizophrenia: Comparison of medicated and drug-free patients, Biol Psychiat1983; 18: 537–551, 1983.
7.
FreedmanRWaldoMBickford-WimerPNagamotoH. Elementary neuronal dysfunction in schizophrenia. Schizophrenia Res1991; 4: 233–243.
8.
NagamotoHTAdlerLEHeaRAGriffithJMMcRaeKAFreedmanR, Gating of auditory P50 in schizophrenics: Unique effects of clozapine. Biol Psychiat1996; 40: 181–188.
9.
WaldoMGerhardtGBakerNDrebingCAdlerLFreedmanR. Auditory sensory gating and catecholamine metabolism in schizophrenic and normal subjects. Psychiat Res1992; 44: 21–32.
10.
AdlerLEHofferLGriffithJWaldoMCFreedmanR. Normalization by nicotine of deficient auditory sensory gating in the relatives of schizophrenics. Biol Psychiat1992; 32: 607–616.
11.
SiegelCWaldoMMiznerGAdlerLEFreedmanR. Defects in sensory gating in schizophrenic patients and their relatives. Arch Gen Psychiat1984; 41: 607–612.
12.
WaldoMCCawthraEAdlerLEDubesterSStauntonM. Auditory sensory gating, hippocampal volume, and catecholamine metabolism in schizophrenics and their siblings. Schizophrenia Res1994; 12: 93–106.
13.
JasperHH. The ten-twenty electrode system of the International Federation. Electroencephalogr Clin Neurophysiol1958; 10: 371–375.
14.
LeonardSAdamsCBreeseCR. Nicotinic receptor function in schizophrenia. Schizophrenia Bull1996; 22: 431–445.
15.
KathmanNEngelRR. Sensory gating in normals and schizophrenics: A failure to find strong P50 suppression in normals. Biol Psychiat1990; 27: 1216–1226.
16.
FranksRDAdlerLEWaldoCLAlpertJFreedmanR. Neurophysiological studies of sensory gating in mania: Comparison with schizophrenics. Biol Psychiat1983; 18: 989–1005.
17.
WaldoMCFreedmanR. Gating of auditory evoked responses in normal college students. Psychiat Res1986; 19: 233–239.
18.
FreedmanRWaldoMWaldoCLWilsonJR. Genetic influences on the effects of alcohol on auditory evoked potentials. Alcohol1987; 4: 249–253.
19.
GuttermanYJosiassenRCBashoreTR. Attentional influence on the P50 component of the auditory event-related potential. Internat J Psychophysiol1992; 12: 197–209.
20.
StruveFAStraumanisJJ. Electroencephalographic and evoked potential methods in human marihuana research: Historical review and future trends. Drug Develop Res1990; 20: 369–388.
PatrickGStraumanisJJStruveFAFitz-GeraldMMannoJ. Early and middle latency evoked potentials in medically and psychiatrically normal daily marihuana users: A paucity of significant findings. Clin Electroencephalogr1997; 28: 26–31.
23.
PatrickGStraumanisJJStruveFA. Auditory and visual P300 event related potentials are not altered in medically and psychiatrically normal chronic marihuana users. Life Sci1995; 56: 2135–2140.
24.
SolowijN. Do cognitive impairments recover following cessation of cannabis use. Life Sci1995; 56: 2119–2126.
25.
SolowijNMichiePTFoxAM. Effects of long-term cannabis use on selective attention: An event-related potential study. Pharmacol Biochem Behav1991; 40: 683–688.
26.
SolowijNMichiePTFoxAM. Differential impairments of selective attention due to frequency and duration of cannabis use. Biol Psychiat1995; 37: 731–739.
27.
StruveFAStraumanisJJPatrickGPriceL. Topographic mapping of quantitative EEG variables in chronic heavy marihuana users: Empirical findings with psychiatric patients. Clin Electroencephalogr1989; 20: 6–13.
28.
StruveFAStraumanisJJPatrickG. Persistent topographic quantitative EEG sequelae of chronic marihuana use: A replication study and initial discriminant function analysis. Clin Electroencephalogr1994; 25: 63–75.
29.
StruveFAStraumanisJJPatrickGLeavittJMannoJEMannoBR. Topographic quantitative EEG sequelae of chronic marihuana use: A replication using medically and psychiatrically screened normal subjects. Drug Alcohol Depend1999; 56: 167–179.
30.
StruveFAMannoBRKempPPatrickG. “Alpha hyper-frontality” during and following inhalation of THC. In: HarrisLS (ed). Problems of Drug Dependence 1995. Washington DC: US Government Printing Office (NIDA Research Monograph 162, NIH Publication No. 96-4116); 1996: 292.
31.
StruveFAMannoBRStraumanisJJ. Theta hypertrontality: An additional quantitative EEG sequelae of acute and chronic marihuana (THC) exposure. International Cannabinoid Research Society, La Grande Motte, France, July 23–25, 1998.
32.
GoffWRWilliamsonPDVan GilderJCAlisonTFisherTC. Neural origins of long latency evoked potentials recorded from the depth and from the cortical surface of the brain in man. Prog Clin Neurophysiol1980; 7: 126–125.
33.
WoodsDLClayworthCCKnightRTSimpsonGVNaeserMA. Generators of middle and long-latency evoked potentials: Implications from studies of patients with bitemporal lesions. Electroencephalogr Clin Neurophysiol1997; 68: 132–148.
34.
Bickford-WimerPCNagamotoHJohnsonR. Auditory sensory gating in hippocampal neurons: A model system in the rat. Biol Psychiat1990; 27: 183–192.
35.
Lunz-LeybmanVBickfordPCFreedmanR. Cholinergic gating of response to auditory stimuli in rat hippocampus. Brain Res1992; 587: 130–136.
36.
MillerCLRoseGMWiserAKFreedmanRBickfordP. Long-term potentiation reduces auditory gating in the CA3 region of the hippocampus. Washington DC: Society of Neuroscience 23rd Annual Meeting, 1993; Abstract 375.18.
37.
MillerCLFreedmanR. The reactivity of hippocampal interneurons and pyramidal cells during the response of the hippocampus to repeated auditory stimuli. Neuroscience1995; 69: 371–381.
38.
McLsaacWMFritcheGEIdanpaan-HeikkilaJEHoBTEnglertLF. Distribution of marihuana in monkey an concomitant behavioural effects. Nature1971; 230: 593–594.
39.
NyeJSSeltzmanHHPittCGSynderSH. High-affinity cannabinoid binding sites in brain membranes labeled with [3H]-5-trimethylammonium Δ8-tetrahydrocannabinol. J Pharmacol Exp Ther1985; 234: 784–791.
40.
DevaneWADysarzFAIIIJohnsonMRMelvinLSHowlettAC. Determination and characterization of a cannabinoid receptor in rat brain. Mol Pharmacol1988; 34: 605–613.
41.
HerkenhamMLynABLittleMD. Cannabinoid receptor localization in brain. Pro Natl Acad Sci USA1990; 87: 1932–1936.
42.
HerkenhamMLynnABJohnsonMRMelvinLSDe CostaBRRiceKC. Characterization and localization of cannabinoid receptors in rat brain: A quantitative in vitro autoradiographic study. J Neurosci1991; 563–583.
43.
HowlettACBidaut-RussellMDevaneWAMelvinLSJohnsonMRHerkenhamM. The cannabinoid receptor biochemical, anatomical and behavioral characterization. Trends Neurosci1990; 13: 420–423.
44.
JansenEMHaycockDAWardSJSeyboldVS. Distribution of cannabinoid receptors in rat brain determined with aminoalkylindoles. Brain Res1991; 575: 93–102.
45.
FeinGBigginsCMacKayS. Cocaine abusers have reduced auditory P50 amplitude and suppression compared to both normal controls and alcoholics. Biol Psychiat1996; 39: 955–965.